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A B S T R A C T
There exists a wide degree of genetic variation within the normal human population which includes disease free
individuals with heterozygote defects in major DNA repair genes. A lack of understanding of how this genetic
variation impacts cellular phenotypes that inform cancer risk post heavy ion exposure poses a major limitation in
developing personalized cancer risk assessment astronauts. We initiated a pilot study with Human Mammary
Epithelial Cell strains (HMEC) derived from wild type, a p16 silenced derivative of wild type, and various genetic
variants that were heterozygote for DNA repair genes; BRCA1, BRCA2 and ATM. Cells strains were exposed to
different high and low LET radiation qualities to generate both simple and complex lesions and centrosome
aberrations were examined as a surrogate marker of genomic instability and cancer susceptibility post different
exposures. Our results indicate that centrosome aberration frequency is higher in the genetic variants under
study. The aberration frequency increases with dose, complexity of the lesion generated by different radiation
qualities and age of the individual. This increase in genomic instability correlates with elevated check-point
activation post radiation exposure. These studies suggest that the influence of individual genetics on cell cycle
regulation could modify the degree of early genomic instability in response to complex lesions and potentially
define cancer predisposition in response to HZE exposure. These results will have significant implications in
estimating cancer susceptibility in genetically variant individuals exposed to HZE particles.
1. Introduction
Astronauts traveling in space are exposed to high charge high en-
ergy (HZE) ions that can generate multiple lesions, including DSBs,
within a single turn of the DNA helix. While redundancies in DNA re-
pair mechanisms (Aparicio et al., 2014; Karran, 2000) effectively re-
move some of these complex lesions, commonly referred to as clustered
damages, those that remain unrepaired or are mis-repaired can cause
local and global genome rearrangements that threaten both the in-
tegrity of the genome and potentiate long term cancer risk (Stephens
2011;Gudowska, 2004). BRCA1, BRCA2, ATM and p16 are four key
genes that play central roles in the maintenance of genomic integrity by
coordinating a delicate balance between DNA repair processes and cell
cycle checkpoint activation. Their broad function as tumor suppressors
is underscored by the fact that germ line mutations in these genes have
been shown to confer an increased susceptibility to different types of
cancer (Walsh et al., 2016;Dilworth, 2000; Ahmed & Rahman, 2006).
ATM is one of the first responders to radiation-induced DNA damage
and orchestrates repair response by phosphorylating chk2
(Matsuoka et al., 2000) and other downstream substrates involved in
checkpoint control, repair, and apoptosis (Falck et al., 2001, Zhou and
Elledge, 2000). Consequently, ATM deficient cells exhibit pronounced
radiosensitivity, failure to initiate cell cycle checkpoints and chromo-
some instability in response to radiation exposure (Kuhne et al., 2004).
BRCA1 is one of the key repair substrates of ATM that is quickly re-
cruited to DNA lesions and participates in DNA repair through asso-
ciation with a number of proteins including Rad51. Essential roles in
numerous pathways including activation and repression of
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transcription, homologous recombination (HR), cell cycle regulation,
check point activation, DNA damage repair, protein ubiquitination,
chromatin remodeling, and apoptosis have been attributed to BRCA1
(Moynahan et al., 1999). In contrast to the multifaceted role of BRCA1,
the main role of BRCA2 is to regulate the proficiency of repair and
recombination processes and maintaining genomic instability by con-
trolling the enzymatic activity of RAD51 (Davies et al., 2001). The
importance of both BRCA1 and BRCA2 in HR is well documented by the
aberrant chromosomal structures and radiosensitivity observed in cells
with defects in these proteins (Patel et al., 1998; Moynahan et al., 1999;
Xu et al., 1999). p16 is a tumor suppressor that functions by inhibiting
the progression from G1 to S phase in response to cellular stresses such
as radiation [Shapiro, 1998]. This is an essential step in the initiation
and maintenance of a stress-associated senescence barrier termed stasis;
the first barrier that limits proliferation potential to prevent im-
mortalization (Garbe et al., 2007). It has been shown that stasis is ac-
companied by increased levels of p16 and can be bypassed by loss of
p16 expression, a phenotype frequently observed in human breast
cancer (Brenner et al., 1996). These studies highlight the distinct roles
of ATM, BRCA1, BRCA2 and p16 in the cellular response to double
strand breaks.
Numerous mutations and polymorphisms have been reported in
BRCA1, BRCA2 and ATM (Karami and Mehdipour, 2013); Choi, 2016].
Mutations in one copy of BRCA1, BRCA2 or ATM have been noted in
∼0.26–0.32%, ∼0.36%, and ∼0.50–1.50% of the general population
respectively (Broeks et al., 2000, Mann et al., 2006, Maxwell et al.,
2016, Swift et al., 1986). While some of these cause nonsynonymous
sequence alterations that adversely affect function and promote carci-
nogenesis, the impact of others are either silent, or in some cases even
been speculated to have a protective role in preventing breast cancer
development (Karami and Mehdipour, 2013). Of interest, rare cells with
spontaneous dysfunction of p16, similar to the phenotype observed in
cancer cells, have also been observed in vivo within normal tissue of
some women (Brenner et al., 1998, Holst et al., 2003, McDermott et al.,
2006). However studies on whether these variants confer increased
cancer risk and differ in their biological response to cell stressors have
been controversial.
It is likely that the astronaut cohort could include some of these
genetic variants. To provide personalized risk assessments for astro-
nauts, NASA has undertaken a monumental effort to factor-in the
weights of various variables such as age, gender and tobacco-use, on the
risk of developing cancer from space radiation exposure. Thus far ge-
netic variation has not been used modeling cancer risk from space ra-
diation exposure. However, as disease-free heterozygote individuals
with defects in major DNA repair genes exist within the normal popu-
lation, a better understanding of how this impacts cancer development
processes at early times post HZE exposure would lay the groundwork
for potentially using genetic variation in informing cancer risk assess-
ments in astronauts.
To test whether genetic variation had an impact on early response to
lesions that differ in complexity, we undertook a small scale study by
comparing a subset of human mammary epithelial cell strains (HMECs)
derived from individuals who are genetic variants, namely hetero-
zygous for BRCA1, BRCA2 and ATM and compared them to a wild type
strain with and without knock down of p16 expression using short hair
pin RNA (shRNA) against p16, which allowed us to examine the da-
mage response phenotype when the stasis barrier is impacted. We ex-
posed HMECs to two different doses of high and low Linear energy
transfer (LET) radiation and compared the frequency of centrosome
aberrations elicited, as a useful surrogate marker to predict genome
instability, at different times post radiation exposure. In the second part
of this study, as drivers of centrosome duplication in radiation induced
carcinogenesis are unclear, we tested the hypothesis that early DNA
Damage Response (DDR) that impacts checkpoint regulation may pre-
dict strain specific changes in centrosome numbers and resulting
genomic instability. Herein we compared centrosome aberration
frequency to the degree of expression and activation of key proteins
involved in checkpoint regulation. Our results suggest that genetic
variants exhibit increased numbers of centrosome aberrations following
exposure to complex damages in comparison to simple damages, in-
duced by high vs low LET radiation respectively. Elevation of key nodes
in check point regulation such as pChk1, pChk2, p53 and ATR appear to
parallel the increase in centrosome aberration frequency.
2. Materials and methods
2.1. Cell strains
We have utilized primary HMEC strains derived from normal and
heterozygote carriers for various DNA repair proteins involved in breast
cancer risk. These include Wild Type (WT) specimen 184D, derived
from a 21y old individual; specimen 90P derived from a non-tumor
mastectomy from a 36y old BRCA1(+/−) individual; specimen 255 L
derived from a prophylactic mastectomy from a 30y old BRCA2(+/−)
individual and specimen 245AT derived from a prophylactic mas-
tectomy from a 41y old ATM (+/−). The study was limited to one
strain for each gene, owing to the availability of only these strains in the
HMEC Bank at the time of study, and the necessity to maintain uni-
formity in strain isolation and culture conditions. To compare the effect
of p16 silencing, that is sporadically observed as part of malignant
progression, the WT 184D strain was compared to its genetically
modified post-stasis derivative, wherein p16 was silenced by retroviral
transduction of p16 shRNA without introducing gross genomic errors
(Garbe et al., 2014). A subset of six primary WT HMEC strains chosen
from a wider cohort of individuals of different ages that were used in
our previous study (Sridharan et al., 2017), were used to examine the
impact of radiation quality on age dependent genomic instability. These
included two pre-stasis strains chosen from individuals in three distinct
age groups: (young: specimen 48R (16y) and 240 L (19y); middle-age:
specimen 60R (47y) and 030 (49y) and old: specimen 71C (65y) and
specimen 122 L (66y). These strains were exposed to a low and high
dose of 93 MeV/u Silicon ions and compared with the same strains
exposed to 300 MeV/u Titanium ions. Samples were processed 9 days
post exposure. Early passages of these finite-lifespan strains were grown
from a large bank of frozen organoids as described (Garbe et al., 2009,
Labarge et al., 2013). Details on the derivation and culture of these
HMECs can be found on the HMEC Bank website, http://hmec.lbl.gov.
All experiments were performed in accordance with relevant guidelines
and regulations approved by Lawrence Berkeley National Laboratory
Human Subjects Committee, IRB protocols 305H002 and 108H004. The
HMEC specimens used in this study were obtained between 1977 and
1981. This was before the current IRB consent regulations were in
place. Consent at that time was covered by the hospitals' consent forms
which gave the pathologists permission to use or distribute discarded
surgical material (which is what was obtained) at their discretion. Our
current IRB protocols (305H002 and 108H004) explicitly allows us to
distribute and use this material.
2.2. Cell culture
Cell strains were obtained from the HMEC bank at 2nd passage (P2)
and were subsequently passaged to generate the required number of P4
cell stock vials at 1×10^6 million cells per ml, for use in all experi-
ments. 4th passage HMEC strains were seeded at the same number for
all strains and grown to sub-confluence (85%confluency∼0.5×10^6
cells) in T75 flasks and exposed to radiation. Serum-free M87A medium
supplemented with 0.5 ng/ml cholera toxin (CT), and 0.1 nM oxytocin
(Bachem) (Garbe et al., 2009) was used to replace the media in culture
flasks every two days and strains were routinely tested for absence of
mycoplasma contamination (Bionique Test Labs, NY), prior to use.
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2.3. Irradiation
Cell strains plated in T75 cm2 (Corning) flasks were exposed in log
phase to different radiation qualities at room temperature. Two para-
meters that define the unique track structure of heavy ion exposures are
LET, defined as the linear energy transferred per unit distance, and Z2/
β2 where Z is the effective charge number of the particle, which ac-
counts for atomic screening effects, and β the velocity of the particle
scaled to the speed of light. Z2/β2 is an accepted equivalent of the
number and intensity of delta rays generated.. Heavy ion exposures
Silicon 93 MeV/u (Si93, LET 152 keV/μm, Z2/β2 1137) and Titanium
300 MeV/u (Ti300, LET 171 keV/μm, Z2/β2 1136) were carried out at
the NASA Space Radiation Laboratory (NSRL) at Brookhaven National
Laboratory, Upton, NY, and characterized by different LET values but
similar Z2/β2 values obtained from NSRL. To prevent particle frag-
mentation, cell culture flasks were placed vertically, perpendicular to
the axis of the horizontal beam, oriented with the cell side closest to the
beam, as illustrated in the beam profile captured by the digital beam
imager at NSRL (https://www.bnl.gov/nsrl/userguide/beam-
uniformity-and-profile.php). The beam diameter was 20×20 cm2
square, with a uniform center and variation of+/− 10% at the per-
iphery. Cells were exposed to either a low dose of 0.05 Gy or high dose
of 0.5 Gy chosen based on effectiveness of this dose in generating
centrosome aberrations as shown previously (Sridharan et al., 2017).
Dosimetry calibration at NSRL was carried out using standardized
techniques outlined in the NSRL user guide (https://www.bnl.gov/nsrl/
userguide/dosimetry-calibration.php). In brief, a small ion chamber
called a "Calibration Ion Chamber" (Far West Technology) routinely
calibrated using a standard gamma ray source (Cs-137), is mounted on
a dual axis drive that allows the remote placement of the device. Once
the beam has been tuned, prior to each set of exposures, the Calibration
Ion Chamber measures the dose delivered by the beam at the same time
as a series of large ion chambers is being read out. This reading serves
to transfer the calibration to the large ion chambers that remain in the
beam just upstream of the samples during exposures. It is these sec-
ondary ion chambers that measure the integrated dose delivered and
cut off the beam when the desired dose has been achieved. Dose rates
ranging from (0.05–0.06) Gy/min for low dose exposures and
(0.22–0.32) Gy/min for high dose exposures were used to maintain
short exposure times (0.5–2 min). Both mock irradiated and Si radia-
tion-exposed cells were cultured and processed at 24 h and 72 h fol-
lowing treatment for multiplexed profiling of proteins involved in DNA
damage response, and the 72 h sample was used to score centrosome
aberrations. An aliquot from both Si 93 and Ti 300 MeV/u exposed
samples were shipped to LBNL to subsequently define centrosome
aberrations in long-term culture (9 days post exposure).
Cells were exposed to Cesium radiation at Lawrence Livermore
National Laboratory at dose rates of ∼0.12 Gy/min for low doses and
∼1.80 Gy/min for high doses and processed similar to the previous
samples. For each cell line, flasks were irradiated using a 137Cs Mark 1
Irradiator (J.L. Shepherd and Assoc., Glendale, CA). The negative
control was sham irradiated. Slightly higher doses of 0.8 and 0.08 Gy
were obtained using 10X and 2X attenuation at dose rates of 0.98 or
0.25 Gy/min, respectively. Based on the known higher effectiveness of
high LET radiation, cells were exposed to slightly higher doses for low
LET cesium to enable dose comparison within each radiation quality.
After irradiation, cells were transferred to 37 °C. TLD dosimeters were
used to calculate dosimetry as standard protocol. Before radiation
treatment, 2–3 TLDs were blanked and placed in locations flasks would
be receiving dose. The measured dose based on TLDs was then defined
for flasks that were subsequently irradiated. Two independent flasks
were set up for each un irradiated control and dosed sample for each
strain. The total number of population doublings for each culture were
calculated, using the formula PD= log2 (recovered viable cell number/
number of viable cells seeded)/0.301. The number of population dou-
blings ranged from ∼1 to 6 in the radiation exposed samples. The
proliferative potential of the pre-stasis strains BRCA1+/−, BRCA2+/
− and ATM+/− strains in M87A media are known range from ∼30 to
50 PD and of the normal strains range from 40 to 60 PD prior to
reaching stasis.
2.4. Centrosome aberrations
Cells following exposure to Cs and Si93 MeV/u were detached from
flasks on Day 2 with trypsin (5min. of 0.05% trypsin +5mM EDTA),
following a PBS wash and plated immediately onto a 15mm round glass
German 1.0 coverslip (Fisher scientific Inc.) at a concentration of
0.2×105 cells/coverslip for analysis on Day 3. Cells were also seeded
at a lower density, 0.5× 105cells/coverslip for controls and dosed
samples, in 60mm dishes and re-plated onto 15mm round glass german
1.0 coverslips on Day 8 at 0.2×105 cells/ coverslip for analysis 9 days
post exposure. Coverslips were fixed in 100% methanol for 10mins at
−20 °C, washed in Phosphate Buffered Saline (PBS) and blocked in 1%
BSA for 1hr at room temperature (RT). Centrosomes were detected by
indirect immunofluorescence, using a primary rabbit antibody against
pericentrin (1:1000) (Abcam, Cambridge MA). Following primary an-
tibody incubation (1 h at RT), the cells were washed three times in
blocking buffer, and subsequently incubated for 0.5 h with goat anti-
rabbit Alexa Fluor 594 (Invitrogen, Waltham MA). Post-secondary an-
tibody incubation, cells were washed twice in PBS, counterstained with
0.1 µg/ml 4′, 6-diamidino-2-phenylindole (DAPI) in PBS, air-dried and
mounted with Vectashield (Vector Laboratories, Burlingame, CA).
Stained cells were imaged with a Zeiss Axiovert 200M inverted fluor-
escence microscope equipped with a cooled CDD camera and Image-
Pro®Plus software (MediaCybernetics, Rockville MD). Image acquisition
was carried out within a week of staining using a 40X air objective.
2.5. Calculation of centrosome aberrations
Centrosome aberrations were scored blind by two independent in-
dividuals. Random regions of the slide were imaged for centrosome
scoring.For each region scored, we assessed the total number of cells
based on DAPI stain, and the number of cells with aberrant centrosomes
(> 2 pericentrin foci). Images of cells containing aberrant centrosome
numbers were taken at 40X to evaluate the number of centrosomes in
each aberrant cell. The majority of the cells in irradiated and uni-
rradiated samples show two pericentrin foci (2P) (Appendix Fig. 7).
Cells with supernumerary centrosomes had between 3 to as many as 8
centrosomes, and were scored as aberrant (> 2P).The number of cen-
trosome aberrations per cell were characterized as either 3 centro-
somes/cell (3P) or greater than 3 centrosomes/cell (> 3P). The data
presented reflect an average of two independent experiments. Between
200 and 400 cells were examined for each sample.
2.6. Multiplex analysis for phospho-protein expression
Two independent samples from each of the strains (WT, WT p16-,
BRCA1+/− and BRCA2+/−) were exposed to Si93 MeV/u or Cs and
examined for the levels of expression of various DNA damage phospho-
proteins. The ATM+/− strain was not used in this assay due to lack of
sufficient cell numbers. Both irradiated and sham samples were pro-
cessed 1 and 3 days post radiation exposure. Processing was staggered
in batches to ensure quality control. After a cold PBS wash, 300 ul of
ice-cold 1X Milliplex lysis buffer (EMD Millipore Inc, MA) with protease
inhibitors (Sigma) and phosphatase inhibitors (1mM sodium orthova-
nadate, Sigma, MO) was added to each plate on ice. Cells were scraped
off the plate, and cell suspensions were transferred to a centrifuge tube
and rocked for 15 min at 4C. Particulates were removed by high-speed
centrifugation at 12,000 rpm for 10 min at 4C, and protein concentra-
tion was determined by bicinchoninic acid assay (BCA assay) using the
NanoDrop spectrophotometer (Thermofisher Scientific, DE). Samples
were aliquoted and stored at −70C following quantification and prior
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to analysis. The MILLIPLEX® MAP 7-plex DNA Damage/Genotoxicity
Magnetic Bead kit (EMD Millipore Inc, MA) was used to detect changes
in phosphorylated Chk1 (Ser345), Chk2 (Thr68), H2AX (Ser139) and
p53 (Ser15) as well as total protein levels of ATR, MDM2 and p21 in cell
lysates. 25 μg of sample was used in each well and the immunoassay
was carried out according to the published protocol for this kit (48–621
MAG, EMD Millipore Inc, MA) and analyzed using the Luminex®
system. Fold changes in overall protein expression or activation were
presented per unit dose and were from an average of two independent
experiments. Errors bars reflect standard deviation between experi-
ments. For each target, the values were background subtracted and
normalized to GAPDH levels for each sample
2.7. Statistical analysis
Statistical analysis and testing were carried out using Graph Pad
Prism. Two-way ANOVA was used for multiple comparisons of relative
centrosome aberration frequency in the variant cell lines compared to
the wild type, to estimate the 95% confidence interval. Adjusted p va-
lues were obtained using Dunnett's test representing correction for
multiple comparisons. Anova was also used for pairwise radiation
quality comparison within each cell line and between high and low
dose. The following notations have been used in graphs to denote sta-
tistical significance; *=p < 0.05, **=p < 0.01, and ***=p < 0.001.
Comparison of differences in the percentage of cells with centrosome
aberrations among dosed and unexposed controls were carried out
using two tailed t test. Pearson correlation was used to examine the
correlation between centrosome aberrations and expression or activa-
tion levels of various key nodes in the DNA damage response. Two-way
ANOVA was used for multiple comparisons of multiplex data. To cor-
rect for false positives with multiple comparisons in multiplexed ana-
lysis, both raw p value score (assuming each target was the only one
scored) and the adjusted p value calculated using the Bonferroni
method, (factoring in the number of targets simultaneously assessed)
were obtained to improve the estimates of significance.
3. Results
3.1. Increased centrosome aberrations in cells with genetic variation in DNA
damage response genes post exposure to HZE ions
We previously showed that complex damages elicit increased cen-
trosome aberrations in an age dependent manner in HMECs
(Sridharan et al., 2017). However, this relationship has not been
characterized in HMECs derived from individuals with genetic varia-
tions. To address how individual genetics influences the development of
surrogate markers of cancer risk, we undertook a pilot study utilizing a
small cohort of well-characterized HMEC strains from individuals with
single allele mutations in repair genes (BRCA1+/−, BRCA2+/−,
ATM+/−), as well as an HMEC strain with or without knock-down of
p16 expression (WT, WTP16(-)) by transduction of shRNA to p16
(Garbe et al., 2014).
Pre-stasis 4th passage strains from WT, WTP16(-) and the genetic
variants were irradiated with a low (0.05 Gy) and high dose (0.5 Gy) of
Si93 MeV/u (Si). Centrosome aberrations 3 days post exposure were
compared to Cesium (Cs) exposed samples at similar doses (Fig. 1). The
frequency of centrosome aberrations was assessed for two independent
experiments. 400 cells were scored for each sample. Aberration fre-
quencies were divided by the number of population doublings (PD) to
correct for population doubling differences and normalized to the sham
radiated controls. Normalized aberration frequency per unit radiation
dose (Gy) was graphed to compare effects at low and high doses. Strain-
specific differences in centrosome aberration frequencies were not ob-
served with low dose Cs exposure (Fig. 1A). Relative to WT, centrosome
aberration frequencies by the majority of the variant strains were lower
with low dose Si 93 MeV/u compared to Cs exposure (Fig. 1A). The
BRCA1+/− carrier strain was an exception, exhibiting a higher aber-
ration frequency with low dose Si exposure that was significant
(p < 0.001) relative to control and relative to the wild type strain WT
(p < 0.05). As fold changes relative to control were graphed, “ * “
alone was used to indicate changes relative to sham irradiated controls,
and horizontal bars were used to indicate pair-wise comparisons. The
ATM+/− strain was not processed following low dose exposure to Si
93 MeV/u due to sample contamination.
When exposed to a high dose of Cs, the BRCA1+/− strain showed
the highest frequency of centrosome aberrations in comparison to the
other strains, which was significantly (p < 0.001) different from its
unirradiated control (Fig. 1B). We noted that the centrosome aberration
frequencies in the p16 silenced WT strain, (p < 0.05), BRCA1+/−
(p < 0.05), BRCA2+/− and ATM+/− strains were higher with high
dose exposure to Si 93 MeV/u in comparison to WT. With high dose
exposure, a significant radiation quality difference (Cs Vs Si93) was
noted in the p16 silenced WT strain (p < 0.01). Interestingly ∼2 fold
increase is noted in the BRCA1+/− strain relative to the BRCA2+/−
strain for both cesium and Si 93 MeV/u exposure. Overall, the genetic
variants showed higher frequencies of centrosome aberrations as com-
pared to the WT in response to complex damages induced by Si
93 MeV/u exposure. Of interest, baseline centrosome aberrations in
unirradiated samples revealed that centrosome aberrations in the het-
erozygote strains were also higher than wild type (Appendix Fig. 1).
However the aberration frequency of the WTP16(-) strain did not sig-
nificantly differ from WT.
3.2. Distribution of the number of centrosomes in aberrant cells post Si ion
exposure
We next focused on the strains that showed an increase in centro-
some aberrations with Si93, to examine whether the type of centrosome
aberration was impacted by genetic background. Aberrant cells (> 2
centrosomes) identified while scoring a minimum of 400 cells were
classified into two sub-groups; cells with 3 pericentrin foci (3P) and
those containing more than 3 pericentrin foci (> 3P). We noted a dose
dependent increase in both the 3P and>3P centrosome subgroups
(Fig. 2A and B). With the exception of BRCA1+/− strain where the
normalized frequency of aberrant cells containing 3 centrosomes was
similar between low and high doses, in all of the other variant strains,
the 3P frequency was elevated with high dose as compared to low dose,
with ATM+/− exhibiting the highest change (Fig. 2A). However, this
increase was not noted in the> 3P population (Fig. 2B), wherein the
frequency in the ATM+/− strain was similar to wild type post high
dose exposure. We also noted that the BRCA1+/− and the p16 si-
lenced strain showed similar increases in the>3P population with high
dose exposure. Together these results point to some strain specific dif-
ferences in the distribution of centrosome aberration with HZE ex-
posure.
3.3. Assessment of key nodes involved in check point regulation post DNA
damage
Given that cell cycle regulation plays a key role in the maintenance
of normal centrosome numbers, we next examined whether proteins
involved in check point activation could provide clues that predict the
differences in centrosome aberration frequency and thus genomic in-
stability post exposure. We assessed the activation of key mediators that
are thought to sustain multi-protein interactions to provide positive
signaling feedback (γH2AX), transducers that phosphorylate check
point kinases (ATM, ATR) and effectors that determine cell fate choices,
such as undergoing cell-cycle arrest or apoptosis in response to radia-
tion damage (P53, MDM2, P21, Chk1, Chk2). We chose a 24 h and 72 h
time point after exposure to understand how persistent DNA damage
(either unrepaired or mis repaired lesions at these time points) would
impact the expression and activation (phosphorylation) of key proteins
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involved in cell cycle regulation that in turn deregulate centrosome
numbers. Due to the observed increase in centrosome aberrations fol-
lowing a high dose of Si 93 MeV/u exposure in Fig. 1, we centered our
analysis on checkpoint protein responses following high dose ex-
posures. Our results revealed that with Cs exposure, both total protein
levels of ATR, MDM2 and p21 and phosphorylated levels of Chk1
(Ser345), Chk2 (Thr68), H2AX (Ser139) and p53 (Ser15) were very
similar in the WT and WTP16(-) strains (Fig. 3A and B). However,
following exposure to Si 93 MeV/u most of these nodes were elevated in
and WTP16(-) culture as compared to the normal pre-stasis strain
(Fig. 3C and D). P21 was the only target that showed no change in
expression with or without P16 expression. 24 h post exposure, pP53
showed the greatest difference between the WT strain and its P16(-)
derivative (Fig. 3C), but at 72 h, pChk2, pChk1, ATR and γH2AX
showed a higher increase in the WTP16(-) culture in comparison to WT
(Fig. 3D). It is notable that in the p16 shRNA post-stasis culture, the
levels of all seven of these proteins was higher post Si 93 ion exposure
as compared to cesium both at 24 h as well as 72 h post exposure.
Comparing changes in protein and phospho-protein expression to cen-
trosome changes (Fig. 3E) an analogous pattern is observed with the
p16 silenced WT sample showing a greater significant effect
(p < 0.05), post exposure to Si 93 MeV/u. Despite the observed simi-
larity in patterns of centrosome aberration frequency and activation of
the seven DNA damage response markers, a significant correlation be-
tween end points was not observed.
Similar to what was observed in the p16(-) post-stasis strain, the
BRCA1+/− strain showed no increase with Cs exposure (Fig. 4A) and
a transient elevation in all of these protein targets at 24 h (Fig. 4C). In
addition to p53, a large variation between WT and BRCA1+/− strains
was noted for γH2AX, ATR and pChk2. The majority of these nodes
continue to remain elevated in the BRCA1+/− strain at 72 h post Si 93
exposure, both in comparison to WT (Fig. 4D) and to cesium exposed
samples (Fig. 4B vs 4D). This increase appears to mimic the increase in
centrosome aberrations noted with Si93 in the BRCA1+/− strain
(p < 0.05) (Fig. 4E), though the statistical correlations weren't sig-
nificant. Notably, differences between the WT and BRCA1+/− strains
appear less than what was observed between WT pre-stasis and p16-
post-stasis culture.
Following cesium exposure there is almost no difference between
WT and BRCA2+/− in the various protein and phospho-protein ex-
pressions (Fig. 5A and B). However, with Si93 exposure the levels of all
of these proteins are much higher in the BRCA2+ /- carrier in com-
parison to WT at 24 h post exposure (Fig. 5C), with γH2AX, pChk1,
pChk2 and p53 showing the largest difference between WT and the
BRCA2+ /- variant. Similar to the BRCA1+/− strain, the BRCA2+/−
strain shows an increase in protein expression levels at 72 h (Fig. 5D)
that parallels the increase in centrosome aberrations noted in the
BRCA2+/− sample when comparing to Cs and Si exposure results
(Fig. 5E). With the exception of p21, BRCA2+/− shows a larger in-
crease in levels of proteins relative to WT. Our results indicate increased
levels of ATR, phospho-p53, γH2AX, p21, MDM2, pChk1 and pChk2
with high dose exposure to Si93 in both of the BRCA variant cell strains
with high dose exposure. This activation continues to persist at longer
times (72 h) post damage. Unlike high dose exposure, the two genetic
variants BRCA1+/− and BRCA2+/−, as well as the WT p16-silenced
culture, exhibit a lower level of expression at 72 h post exposure as
compared to the WT pre-stasis strain following low dose exposure to Cs
that results in more simple lesions (Appendix Figs. 2B, 3B and 4B).
These findings appear to parallel the lower level of centrosome aber-
rations with these exposures. Interestingly, while the levels of expres-
sion are higher in all of the genetic variants at 24 h post Si 93 exposure
(Appendix Figs. 2C, 3C and 4C), we noted a different pattern at 72 h.
Fig. 1. Centrosome aberrations are higher in
genetic variants following high dose exposure
to Si 93 MeV/u
Five HMEC strains derived from individuals of
various genetic backgrounds were exposed to a
single low dose (LD) and a high dose (HD) of
two types of radiation, namely Cs and Si
93 MeV/u. These include: (1) a 184 strain used
as a wild type (WT) reference, (2) a WT P16(-)
strain wherein p16 is silenced, (3) a BRCA2+/
− strain (4) a BRCA1+/− and (5) an ATM
+/− strain. Slides were fixed 3 days post ex-
posure and centrosomes were visualized by
indirect immunofluorescence microscopy
using an anti-pericentrin antibody. The fre-
quency of aberrant centrosomes were normal-
ized to sham irradiated controls and aberrations generated by low dose (Fig. 1A) and high dose (Fig. 1B) were graphed per unit dose. As the normalized data was
graphed per unit dose (Gy), error bars were not plotted on the graphs. Cs and Si exposed samples were distinguished by grey and black lines respectively. Data is
based on two independent experiments with error bars representing SD. Notations; *=p < 0.05, **=p < 0.01, ***=p < 0.001 alone were used to indicate
changes relative to sham irradiated controls, and horizontal bars with notations “*” were used to indicate significance of pair-wise comparisons.
Fig. 2. The number of aberrant centrosomes per cell
generated by complex lesions is dependent on the
genetic background.
Cells with centrosome aberrations generated by high
dose exposure to Si 93 MeV/u were further stratified
into two populations, one with 3 centrosomes (3P=3
pericentrin foci) and those that had 4 or more cen-
trosomes (> 3P pericentrin foci). The fraction of cells
with 3P and> 3P were graphed relative to control.
The dose effect on the change in 3P (A) and> 3P (B)
population relative to the un-irradiated control is
shown for all strains. Data for the ATM+/− HD
sample is represented by a square marker.
(*=p < 0.05, **=p < 0.01, ***=p < 0.001).
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Although the expression levels in the p16 silenced culture were similar
and slightly lower than the WT pre-stasis HMEC (Appendix Fig. 2D), the
levels in BRCA1+/− and BRCA2+/− were higher (Appendix Figs. 3D
and 4D), which reflects the pattern of centrosome aberrations in each of
these strains (Appendix Figs. 2E, 3E and 4E), relative to WT.
Although centrosome aberrations at 72 h revealed a similar pattern
of increase with protein and phospho-protein expression for each of the
variant strains, overall a significant correlation between centrosome
aberration frequencies and any of the seven DNA damage response
markers was not observed. However, not surprisingly, we did note a
strong correlation amongst some of the DNA repair nodes, which con-
firmed their documented interaction in DNA damage response. ATR
levels showed a significant correlation with pChk1(p < 0.05), γH2AX
(p < 0.05) and MDM2(p < 0.001); pChk1 levels showed significant
correlation with pChk2 (p < 0.05), γH2AX(p < 0.05), p53 (p < 0.05)
and MDM2 (p < 0.005), pChk2 levels showed a strong correlation with
MDM2 (p < 0.05) and pP53(p < 0.001) and γH2AX levels showed a
significant correlation with phospho-p53 (p < 0.05) and MDM2
(p < 0.05).
3.4. Long-term increase in centrosome aberration frequencies post exposure
to Si 93 Mev/u is independent of genetic background
Given levels of several of the nodes involved in check point reg-
ulation show higher levels in the genetic variant strains and the p16
silenced WT derivative as compared to wild type at 72 h, we next ex-
amined whether this would have an impact on the frequency of cen-
trosome aberrations after a couple of division cycles post exposure. To
assess the temporal dependence of centrosome induction, we scored
centrosome aberrations 9 days post Cs and Si 93 MeV/u exposure. Our
data revealed that the frequency of centrosome aberrations increased
notably for all of the heterozygote strains with Si 93 MeV/u as com-
pared to Cs exposed samples (Fig. 6). Unlike the results observed at Day
3, this increase was noted with both low and high doses (Fig. 6A and B)
with the WTp16 knockdown and BRCA2+/− showing significant in-
creases relative to control (p < 0.001). The frequency of centrosome
aberrations in the WT cell strain as compared to its genetically silenced
P16(-) derivative revealed that aberrations were relatively higher in the
pre-stasis Vs post-stasis culture following both high and low dose
Fig. 3. Comparison of DNA response multiplex
analysis in WT and WT p16 silenced derivative
post radiation exposure.
WT 184D HMEC with and without p16 silencing
were exposed to a low and a high dose of either
Cs or Si93 MeV/u. Cell lysates at 24 h and 72 h
post exposure were processed using the MILLIP-
LEX® MAP 7-plex DNA Damage/Genotoxicity
Magnetic Bead kit (EMD Millipore Inc, MA) to
detect MFI in phosphorylated Chk1 (Ser345),
Chk2 (Thr68), H2AX (Ser139) and p53 (Ser15)
as well as total protein levels of ATR, MDM2 and
p21 in cell lysates using the Luminex system. The
average MFI per unit dose for high dose exposed
samples relative to control and standard devia-
tion of two independent experiments were
graphed. Levels of the various targets in wild
type (black diamond marker) marker were
compared to the genetic variant (white square
marker), the p16 silenced strain (Fig. 3-A, B, C,
D). Up/down bars were used to highlight trends
in the genetic variants relative to wild type.
Levels higher than wild type are represented by
dark shaded bars and lower than wild type are
represented by white shaded bars. Expression of
targets between strains were compared to the
centrosome aberration frequencies in Fig. 3E.
(*=p < 0.05, **=p < 0.01, ***=p < 0.001).
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exposure to Si 93 MeV/u. Centrosome aberration levels were higher at
Day 9 (Fig. 6) as compared to Day 3 (Fig. 1) for most of the cell strains,
with the exception of the p16 silenced and ATM+/− strains where
levels were lower. These results suggest that the long term impact of
complex lesions on genomic instability is independent of genetic
background.
3.5. Centrosome aberrations in genetic variants are dependent on radiation
type
We next posed the question whether centrosome aberration fre-
quency could be modified by the nature of complex lesion inducing
exposure. To address this query, we examined centrosome aberrations
in WT, BRCA2+/−, BRCA1+/− and ATM+/− strains 9 days post
exposure to a high dose of Ti300 MeV/u (0.5 Gy) ion, a radiation
quality that has a higher energy than Si 93, and higher degree of energy
deposited per unit distance in the cell (a higher Linear energy transfer,
LET). Unlike Si93 MeV/u, where the BRCA2+/− strain shows the
highest level of aberrations as compared to the BRCA1+/− and ATM
+/− strains, with Ti300 MeV/u exposure we see an inverse pattern
with the ATM+/− strain exhibiting the highest level of aberrations
(p < 0.01) (Fig. 7).
3.6. Validating the linear relationship between age and centrosome
aberration based on lesion complexity
As radiation quality effects were difficult to discern when com-
paring genetic variants, we attempted to tease out the difference in
effectiveness of Si 93 MeV/u and Ti 300 MeV/u using a subset of the
aged cohort of cell strains (2 young, 2 middle aged and 2 older strains)
previously shown to exhibit an age effect with high dose Ti 300 MeV/u
exposure (Sridharan et al., 2017). Centrosome aberrations were as-
sessed 9 days post exposure. Our results revealed a similar age depen-
dent increase with exposure to Si 93 MeV/u with a steeper slope than Ti
300 MeV/u (Fig. 8). These results demonstrated that the lower energy
ions, such as Si 93 MeV/u are more effective in generating centrosome
aberrations as compared to higher energies like Ti 300 MeV/u and that
age impacts the levels of aberrations.
Fig. 4. Expression and activation of DNA da-
mage cell cycle check point regulation proteins
in WT and BRCA1+/− strain
Strains were exposed to radiation and pro-
cessed similar to Fig. 3. The average MFI per
unit dose for high dose exposed samples re-
lative to control and standard deviation of two
independent experiments were graphed. The
expression and activation of the multiplexed
proteins were assayed between WT and
BRCA1+/− with cesium exposure (Fig 4A and
B) and Si 93 exposure (Fig 4C and 4D). The
pattern of expression was compared to cen-
trosome aberration frequencies at 72 h post
exposure (Fig 4E). (*=p < 0.05,
**=p < 0.01, ***=p < 0.001).
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Fig. 5. Expression and activation of DNA da-
mage cell cycle check point regulation proteins
in WT and BRCA2+/− strains
The BRCA2+/− strain was processed similar
to p16(-) strain and the BRCA1+/− strains
(Fig. 3 and 4) and compared to wild type. The
average MFI per unit dose for high dose ex-
posed samples relative to control and standard
deviation of two independent experiments
were graphed. The expression and activation of
the multiplexed proteins were assayed between
WT and BRCA2+/− with cesium exposure
(Fig. 5A and B) and Si 93 exposure (Fig. 5C and
4D). The pattern of expression was compared
to centrosome aberration frequencies at 72 h
post exposure (Fig. 5E). (*=p < 0.05,
**=p < 0.01, ***=p < 0.001).
Fig. 6. Centrosome aberrations generated by
complex damages at 9 days post exposure are
independent of genetic background.
Wild type and genetic variant strains were
exposed to a high and low dose of Cs and Si
and cultured for 9 days prior to fixation. Slides
were stained with anti-pericentrin antibody
and centrosome aberrations were scored si-
milar to the Day 3 samples. The frequency of
aberrant centrosomes generated by low dose
exposure (Fig. 6A) and high dose exposure
(Fig. 6B) were normalized to sham radiated
controls. Cs and Si exposed samples were dis-
tinguished by grey and black lines. Data is
based on two independent experiments with
error bars representing SD. (*=p < 0.05,
**=p < 0.01, ***=p < 0.001).
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4. Discussion
Our main goal was to test whether genetic variation confers in-
creased risk for the development of cancer predisposing phenotypes
post exposure to HZE radiation. We chose to study centrosome aber-
rations as our surrogate end point of cancer risk, as it has been well
documented that aberrations in centrosome number can disrupt tissue
architecture and genomic instability; the two main hallmarks of carci-
nogenesis (Nigg, 2006; Rivera-Rivera & Saavedra, 2016). We and others
have also shown that centrosome defects increase with simple and
complex damage (Sato et al., 1983; Sudo et al., 2008, Sridharan et al.,
2017) and can sensitively differentiate between radiation and age de-
pendent effects (Sridharan et al., 2017). However, the influence of in-
dividual genetics in eliciting centrosome defects with exposure to
complex damages is not well-understood.
In this study, we have shown that HMEC strains derived from in-
dividuals who are heterozygote carriers of ATM, BRCA1, BRCA2 mu-
tations have an increased frequency of centrosome aberrations fol-
lowing exposure to Si 93 MeV/u relative to a WT non-carrier individual.
There is overwhelming evidence that indicate that complex lesions that
result from the unique track structure of high LET, result in persistent
damage that lasts days to weeks post exposure. We have also shown
that exposure to Si93 MeV/u results in a higher degree of persistent
signaling of various repair response proteins, 24 h post exposure in
comparison to low LET radiation (Sridharan et al., 2015). Thus it is
tempting to speculate that the increase in aberrations with high LET is
directly due to sensitivity to complex damages in these strains. Future
work using live cell microscopy to combine these endpoints would be
useful to validate this relationship. Centrosome over-duplication during
prolonged cell cycle arrest, failure of cell division post centrosome
duplication and centrosome fragmentation from radiation exposure
(Godinho and Pellman, 2014; Nigg, 2006) are potential theories that
could explain the increase in centrosome numbers. We have shown a
notable increase in the activation of proteins/phospho-proteins in-
volved in DNA damage checkpoint activation such as γH2AX, ATR,
pChk1, pChk2 and p53 in the heterozygote strains and the p16 silenced
culture exposed to high doses of Si 93MeV/u. While differences be-
tween normal and Het strains, and correlations between centrosome
aberrations and DNA damage response markers show similar patterns,
the results are not statistically significant. A higher n in future experi-
ments would help in addressing the significance of the observed pat-
terns. Though the trends observed are not significant, our results sug-
gest important correlations that may have mechanistic implications.
Nevertheless, these data provide indirect evidence to suggest that
centrosome duplication during prolonged checkpoint arrest elicited by
complex lesions is a causal factor for increased aberrations in these
strains. However, additional studies directly examining cell cycle arrest
would be essential to confirm this finding.
Our study has revealed that following a high dose of radiation ex-
posure haploinsufficiency of BRCA1 produces a much higher frequency
of centrosome aberrations than that observed in the ATM+/− or
BRCA2+/− carriers. Both ATM and BRCA1 are known to have im-
portant roles in regulating activation of cell cycle checkpoints and in-
ducing arrest in response to DSB damage. BRCA1 not only regulates G1/
S, S, G2/M transition but also regulates the spindle checkpoint that is
critical for chromosome segregation (Deng, 2006; Wang et al., 2004). In
addition, several lines of evidence point to a key role of BRCA1 in
centrosome duplication. This multifaceted protein has been shown to
interact with gamma tubulin, a well-known component of the centro-
some, several proteins (p53, BRCA2, Rb, CDK2-CyclinA and CDK2-cy-
clin E) that play key roles in centrosome duplication (Fukasawa et al.,
1996; Hinchcliffe et al., 1999; Hollander et al., 1999; Hsu and White,
1998; Mantel et al., 1999; Meraldi and Nigg, 2002; Meraldi et al., 1999;
Tutt et al., 1999) and regulates transactivation of specific genes in-
volved in centrosome duplication, such as p21 and Gadd45 (Harkin
et al., 1999; Somasundaram et al., 1997). The nature of post transla-
tional modifications (hypo- versus hyper-phosphorylation) of BRCA1 is
also thought to provide a switch controlling centrosome duplication
(Deng, 2002). Furthermore, studies have shown that in addition to
DSBs, BRCA1 is involved in the repair of non-DSB clustered lesions,
Fig. 7. Lower energy exposures are more biologically effective in generating
centrosome aberrations.
WT, BRCA1+/−, BRCA2+/− and ATM+/− strains were exposed to high
doses of Cs, Si 93 and Ti 300 MeV/u and processed 9 days post exposure for
immunofluorescent microscopy. The percentage of aberrant cells in each strain
was plotted relative to the unexposed population. Data is based on 2 in-
dependent experiments for Cs, Si93 and Ti300. The normalized frequency of
cells with supernumerary (> 2N) centrosomes was graphed per unit dose.
Fig. 8. Validation of an age effect on centro-
some aberration levels with exposure to Si
93 MeV/u.
Six HMEC strains derived from individuals of
various ages (2 young, 2 middle and 2 old)
were exposed to a low dose 0.05 Gy (LD) and
high dose 0.5 Gy (HD) of two types of ions that
introduce complex damages; namely Ti
300 MeV/u and Si 93 MeV/u. Cells were pro-
cessed 9 days post exposure and the percentage
of aberrant cells (> 2P) in each strain was
plotted relative to the unexposed population.
Data is based on 4 independent experiments for
high dose Ti 300 MeV/u and 2 independent
experiments for Si 93 MeV/u. The frequency of
cells with supernumerary (> 2N) centrosomes
was graphed against age of the individual from which the strain was derived. Regression analysis was used to model the relationship with age. The effects of lesion
complexity on the relationship with age is graphed for low (C) and high dose (D). Si 93 and Ti 300 MeV/u regression curves were distinguished using black and grey
dotted lines, respectively.
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oxidative lesions [Hair, 2010], and enhancing the Base excision repair
pathway [Saha, 2010]; functions that are thought to be supported by its
multifaceted role as a coordinator various DNA repair proteins as ex-
pounded by the BASC model [Wang, 2000]. Cumulatively, its combined
functions in regulation of centrosome duplication, check point activa-
tion and damage of DSB and non-DSB lesions in clustered damages,
could explain the higher frequency of aberrations in BRCA1+/− car-
riers as opposed to the BRCA2+/− and ATM+/− strains. With low
doses of Si93 MeV/u exposure, even when only ∼25% of the cells are
directly damaged by exposure, BRCA1+/− cells still exhibit higher
centrosome aberration frequencies. This increased genomic instability
in the BRCA1+/− strain at low doses as compared to BRCA2+/− and
ATM+/− heterozygote strains, suggests that BRCA1 carriers are ex-
quisitely sensitive to the non-targeted effects of Si ion exposure.
ATM acts a sensor of DNA damage and similar to BRCA1, ATM
activation can arrest cells in all three phases (G1, S or G2) of the cell
cycle by phosphorylation of different targets p53, cAbl, Chk1, Chk2 etc
(Baskaran et al., 1997; Canman et al., 1998; Khanna et al., 1998;
Shafman et al., 1997). ATM also localizes to the centrosome and in-
teracts with gamma tubulin, P21 and P53 in regulating centrosome
biogenesis (Shen et al., 2006), all of which support the increased cen-
trosome aberration in the ATM+/− strain relative to WT. Unlike
BRCA1 and ATM, a direct role in regulating cell cycle checkpoints has
not been established for BRCA2. Although BRCA2 loss of function
mutations appear to suggest defects in checkpoint control
(Daniels et al., 2004), disruption of BRCA2 does not have a marked
effect on cell cycle checkpoint control (Patel et al., 1998), which could
explain the lower frequency of centrosome aberrations in BRCA2 in
comparison to BRCA1 and ATM heterozygote strains at early times
following exposure to high doses of Si 93 MeV/u. Interestingly, the
centrosome aberration frequency is lower in both the BRCA1 and ATM
heterozygote strains in comparison to BRCA2+/−, 9 days post Si
93 MeV/u exposure. One likely possibility for this finding is that severe
genomic instability in these BRCA1 and ATM strains at early time points
targets these cells for apoptosis. Thus the BRCA2 heterozygote strain
with a better proliferative advantage is perceived more genomically
unstable 9 days post exposure.
Given the common loss of p16 protein expression observed during
breast carcinogenesis in vivo, including the finding of rare p16- cells
within the breast tissue of some normal individuals, we examined a
wild type normal pre-stasis cell strain and its p16 silenced post-stasis
derivative to test whether overcoming the stasis senescence barrier
could alter surrogate phenotypes associated with carcinogenesis. It has
been previously shown that transduction of p16 shRNA significantly
decreased p16 expression in this cell strain without altering the normal
karyotype (Garbe et al., 2014; Lee et al., 2015). Our studies indicate
that centrosome aberrations generated in the background of loss of p16
expression are higher following complex damages as compared to ex-
posures causing more simple lesions. In fact, higher doses showed sig-
nificantly more aberrations per unit dose than low dose exposures.
Studies by McDermott et al have shown that loss of p16 can generate
supernumerary centrosomes through centriole pair splitting that po-
tentiates genomic instability and results in aneuploidy by generating
multipolar mitosis (McDermott et al., 2006). The ability to amplify
centrosome numbers appears to be through its regulation of cdk2 ac-
tivity, which is essential for initiation of normal centrosome duplication
(Lacey et al., 1999; Matsumoto et al., 1999; Meraldi et al., 1999).
Furthermore, the increase in centrosome numbers associated with p16
loss appears to be coupled with conditions that inhibit DNA replication
(McDermott et al., 2006). Thus, previous work in combination with our
own supports the possibility that complex damage exposures may stall
DNA replication and cause more centrosome aberrations in strains with
a p16 deficient background.
Its well-recognized that individual response to varied exposures can
differ greatly. Our studies have revealed that differences in age, the
complexity of lesion, and the genetic background of the exposed
individual may all play a role. Although pairwise comparison of doses,
and radiation quality within each cell line showed few significant hits,
analysis of trends comparing the variant cell lines as a group to wild
type, revealed significant differences in radiation quality (Cs Vs Si93, p
value= 0.008), and cell type differences (p=0.05) in the Day3 high
dosed exposed samples; and significant dose effects in D3 Cs
(p=0.009), D9 Cs (p=0.05) and Day9 Si 93 MeV/u (p=0.02). We
have also observed that the radiation quality of the exposure plays a
role in the differences observed in the context of age. This finding is
revealed by the lower energy ion, Si 93 MeV/u showing more effec-
tiveness in generating centrosome aberrations as compared to Ti
300 MeV/u, in the aged cohort. Despite similarities in Z2/β2 values of
these two radiation qualities, the inherent track structure is different for
these two ions. Si 93 ions have a lower LET (150 keV/μm) and smaller
track width (525 μm), but has more hits in the cell core (0.84) and more
hits in the penumbra (6.6) in comparison to Ti 300 ions which have a
higher LET (171 keV/μm) and larger track width (3371 μm), but has
fewer hits in the cell core (0.73) and fewer hits in the penumbra (5.5.).
This increased deposition of hits close to the track, could account for
the higher effectiveness of Si93 in comparison to Ti 300 MeV/u. These
results parallel our previous data that show higher effectiveness of
lower energy ions in generating both initial and persistent damage post
exposure to complex lesions (Sridharan et al., 2015). Although both
radiation qualities show a similar age dependent increase, Si ions show
a steeper response slope in the aged cohort and validate our previous
finding of age-related increase in centrosome aberration with lesion
complexity.
In summary, efforts to understand radiosensitivity of genetic var-
iants such as ATM, BRCA1 and BRCA2 heterozygotes and their re-
lationship to breast cancer susceptibility is a topic that has been fraught
with significant controversy with some studies showing enhanced
radiosensitivity in heterozygotes in comparison to the normal popula-
tion (Abbott et al., 1999; Paterson et al., 1979; Weeks et al., 1991)
while others suggesting that cellular radiosensitivity is not altered in
carriers (Weissberg et al., 1998). Lack of clarity on the susceptibility
conferred by genetic variation poses barriers in estimating in-
dividualized cancer risk from radiation exposures, especially those that
generate clustered lesions. Our pilot study has provided promising re-
sults which indicate that in addition to radiation quality, dose and
complexity of the DNA lesion generated by lower energy ions, genetic
background appears to have a significant impact on genomic instability
at early time points post high LET exposure. This increase in centro-
some aberration is likely caused by persistent damage and prolonged
check point activation. A more expansive study including more strains
for each genetic variant is essential to assign weights for genetic var-
iation for use in cancer risk modeling from HZE exposure.
Author contributions statement
J.M.P and D.M.S designed and planned the experiments, J.M.P.,
D.M.S and S.E conducted the experiments, D.M.S., C.W., and S.E.,
analyzed the results, M.A.L and M.S generated and provided cell strains
at P2 and consulted on experimental design. D.M.S. wrote the manu-
script. All authors reviewed the manuscript.
Acknowledgements
We thank our research assistants Mary Whalen, Wade Wilson and
Jonathan Lee for generating cell stocks and undergraduate volunteers,
Jessica Chen and Roshni Narasimhan for their assistance with micro-
scopy and centrosome scoring. Our thanks to Drs. Sasha Langley and
Ben Brown at LBL for statistical analysis consultation. We also thank the
physics and medical teams at Brookhaven National Laboratory for
supporting the high LET experiments. Lastly, we thank Dr. Matthew
Coleman, Nicholas Hum, and Salustra Urbin at Lawrence Livermore
National Laboratory for supporting the cesium experiments.
D.M. Sridharan et al. Life Sciences in Space Research 20 (2019) 101–112
110
Funding statement/Grant sponsors
NASA grants NNJ13HA96I and NNJ12HD071 awarded to JMP
funded this study. Funds from DOE Laboratory Directed Research and
Development, contract no DE-AC02-05CH11231, NIH R01AG040081
and DOD BC141351 awarded to MAL funded the development of the
strains used from the HMEC Aging Resource.
Conflict of interest
The authors declare no competing financial interests.
Supplementary materials
Supplementary material associated with this article can be found, in
the online version, at doi:10.1016/j.lssr.2018.10.002.
References
Abbott, D.W., Thompson, ME, Robinson-Benion, C, Tomlinson, G, Jensen, RA, Holt, JT.,
1999. BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells
through enhancement of transcription-coupled DNA repair. J. Biol. Chem. 274 (26),
18808–18812.
Ahmed, M., Rahman, N., 2006. ATM and breast cancer susceptibility. Oncogene 25 (43),
5906–5911.
Aparicio, T., Baer, R, Gautier, J, 2014. DNA double-strand break repair pathway choice
and cancer. DNA Repair 19, 169–175.
Baskaran, R., Wood, LD, Whitaker, LL, Canman, CE, Morgan, SE, Xu, Y, Wang, JY, 1997.
Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to
ionizing radiation. Nature 387 (6632), 516–519.
Brenner, A.J., Paldugu, A., Wang, H., Olopade, O.I., Dreyling, M.H., Aldaz, C.M., 1996.
Preferential loss of expression of p16(INK4a) rather than p19(ARF) in breast cancer.
Clin. Cancer Res. 2 (12), 1993–1998.
Brenner, A.J., Stampfer, M.R., Aldaz, C.M., 1998. Increased p16 expression with first
senescence arrest in human mammary epithelial cells and extended growth capacity
with p16 inactivation. Oncogene 17 (2), 199–205.
Broeks, A., Urbanus, J.H., Floore, A.N., Dahler, E.C., Klijn, J.G., Rutgers, E.J., van't Veer,
L.J., 2000. ATM-heterozygous germline mutations contribute to breast cancer-sus-
ceptibility. Am. J. Hum. Genet. 66 (2), 494–500.
Canman, C.E., Lim, D.S., Cimprich, K.A., Taya, Y., Tamai, K., Sakaguchi, K., Siliciano,
J.D., 1998. Activation of the ATM kinase by ionizing radiation and phosphorylation
of p53. Science 281 (5383), 1677–1679.
Daniels, M.J., Wang, Y., Lee, M., Venkitaraman, A.R., 2004. Abnormal cytokinesis in cells
deficient in the breast cancer susceptibility protein BRCA2. Science 306 (5697),
876–879.
Davies, A.A., Masson, J.Y., Mcllwrath, M.J., Stasiak, A.Z., Stasiak, A., Venkitaraman, A.R.,
West, S.C., 2001. Role of BRCA2 in Control of the RAD51 Recombination and DNA
Repair Protein. Mol. Cell 7 (2), 273–282.
Deng, C.X., 2002. Roles of BRCA1 in centrosome duplication. Oncogene 21 (40),
6222–6227.
Deng, C.X., 2006. BRCA1: Cell cycle checkpoint, genetic instability, DNA damage re-
sponse and cancer evolution. Nucl. Acids Res. 34 (5), 1416–1426.
Falck, J., Mailand, N., Syljuasen, R.G., Bartek, J., Lukas, J., 2001. The ATM-Chk2-Cdc25A
checkpoint pathway guards against radioresistant DNA synthesis. Nature 410 (6830),
842–847.
Fukasawa, K., Choi, T., Kuriyama, R., Rulong, S., Vande Woude, G.F., 1996. Abnormal
centrosome amplification in the absence of p53. Science 271 (5256), 1744–1747.
Garbe, J.C., Bhattacharya, S., Merchant, B., Bassett, E., Swisshelm, K., Feiler, H.S.,
Stampfer, M.R., 2009. Molecular distinctions between stasis and telomere attrition
senescence barriers shown by long-term culture of normal human mammary epi-
thelial cells. Cancer Res. 69 (19), 7557–7568.
Garbe, J.C., Holst, C.R., Bassett, E., Tlsty, T., Stampfer, M.R., 2007. Inactivation of p53
function in cultured human mammary epithelial cells turns the telomere-length de-
pendent senescence barrier from agonescence into crisis. Cell Cycle 6 (15),
1927–1936.
Garbe, J.C., Vrba, L, Sputova, K, Fuchs, L, Novak, P, Brothman, AR, Jackson, M, Chin, K,
LaBarge, MA, Watts, G, Futscher, BW, Stampfer, MR., 2014. Immortalization of
normal human mammary epithelial cells in two steps by direct targeting of senes-
cence barriers does not require gross genomic alterations. Cell Cycle 13 (21),
3423–3435.
Godinho, S.A., Pellman, D., 2014. Causes and consequences of centrosome abnormalities
in cancer. Philos. Trans. R. Soc. Lond. B Biol. Sci. 369, 1650.
Harkin, D.P., Bean, JM, Miklos, D, Song, YH, Truong, VB, Englert, C, Christians, FC,
Ellisen, LW, Maheswaran, S, Oliner, JD, Haber, DA., 1999. Induction of GADD45 and
JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. Cell 97
(5), 575–586.
Hinchcliffe, E.H., Li, C, Thompson, EA, Maller, JL, Sluder, G., 1999. Requirement of Cdk2-
cyclin E activity for repeated centrosome reproduction in Xenopus egg extracts.
Science 283 (5403), 851–854.
Hollander, M.C., Sheikh, MS, Bulavin, DV, Lundgren, K, Augeri-Henmueller, L, Shehee, R,
Molinaro, TA, Kim, KE, Tolosa, E, Ashwell, JD, Rosenberg, MP, Zhan, Q, Fernández-
Salguero, PM, Morgan, WF, Deng, CX, Jr, FornaceAJ, 1999. Genomic instability in
Gadd45a-deficient mice. Nat. Genet. 23 (2), 176–184.
Holst, C.R., Nuovo, GJ, Esteller, M, Chew, K, Baylin, SB, Herman, JG, Tlsty, TD., 2003.
Methylation of p16INK4a promoters occurs in vivo in histologically normal human
mammary epithelia. Cancer Res. 63 (7), 1596–1601.
Hsu, L.C., White, R.L., 1998. BRCA1 is associated with the centrosome during mitosis.
Proc. Natl. Acad. Sci. USA 95 (22), 12983–12988.
Karami, F., Mehdipour, P., 2013. A comprehensive focus on global spectrum of BRCA1
and BRCA2 mutations in breast cancer. BioMed Res. Int. 21 2013.
Karran, P., 2000. DNA double strand break repair in mammalian cells. Curr. Opin. Genet.
Dev. 10 (2), 144–150.
Khanna, K.K., Keating, KE, Kozlov, S, Scott, S, Gatei, M, Hobson, K, Taya, Y, Gabrielli, B,
Chan, D, Lees-Miller, SP, Lavin, MF., 1998. ATM associates with and phosphorylates
p53: mapping the region of interaction. Nat. Genet. 20 (4), 398–400.
Kuhne, M., Riballo, E, Rief, N, Rothkamm, K, Jeggo, PA, Löbrich, M., 2004. A double-
strand break repair defect in ATM-deficient cells contributes to radiosensitivity.
Cancer Res. 64 (2), 500–508.
LaBarge, M.A., Garbe, J.C., Stampfer, M.R., 2013. Processing of human reduction mam-
moplasty and mastectomy tissues for cell culture. J. Vis. Exp. 71.
Lacey, K.R., Jackson, P.K., Stearns, T., 1999. Cyclin-dependent kinase control of centro-
some duplication. Proc. Natl. Acad. Sci. USA 96 (6), 2817–2822.
Lee, J.K., Garbe, J.C., Vrba, L, Miyano, M., Futscher, B.W., Stampfer, M.R., LaBarge, M.A.,
2015. Age and the means of bypassing stasis influence the intrinsic subtype of im-
mortalized human mammary epithelial cells. Front. Cell Dev. Biol. 3, 13.
Mann, G.J., Thorne, H, Balleine, RL, Butow, PN, Clarke, CL, Edkins, E, Chenevix-Trench,
G., 2006. Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the
kConFab familial breast cancer resource. Breast Cancer Res. 8 (1), R12.
Mantel, C., Braun, SE, Reid, S, Henegariu, O, Liu, L, Hangoc, G, Broxmeyer, HE., 1999.
p21(cip-1/waf-1) deficiency causes deformed nuclear architecture, centriole over-
duplication, polyploidy, and relaxed microtubule damage checkpoints in human
hematopoietic cells. Blood 93 (4), 1390–1398.
Matsumoto, Y., Hayashi, K., Nishida, E., 1999. Cyclin-dependent kinase 2 (Cdk2) is re-
quired for centrosome duplication in mammalian cells. Curr. Biol. 9 (8), 429–432.
Matsuoka, S., Rotman, G, Ogawa, A, Shiloh, Y, Tamai, K, Elledge, SJ., 2000. Ataxia tel-
angiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc. Natl. Acad. Sci.
USA 97 (19), 10389–10394.
Maxwell, K.N., Domchek, SM, Nathanson, KL, Robson, ME., 2016. Population frequency
of germline BRCA1/2 mutations. J. Clin. Oncol. 34 (34), 4183–4185.
McDermott, K.M., Zhang, J, Holst, CR, Kozakiewicz, BK, Singla, V, Tlsty, TD, 2006.
p16INK4a prevents centrosome dysfunction and genomic instability in primary cells.
PLoS Biol. 4 (3), E51.
Meraldi, P., et al., 1999. Centrosome duplication in mammalian somatic cells requires
E2F and Cdk2-cyclin A. Nat. Cell Biol. 1 (2), 88–93.
Meraldi, P., Nigg, E.A., 2002. The centrosome cycle. FEBS Lett. 521 (1–3), 9–13.
Moynahan, M.E., Chiu, JW, Koller, BH, Jasin, M., 1999. Brca1 controls homology-directed
DNA repair. Mol. Cell 4 (4), 511–518.
Nigg, E.A., 2006. Origins and consequences of centrosome aberrations in human cancers.
Int. J. Cancer 119 (12), 2717–2723.
Patel, K.J., Yu, VP, Lee, H, Corcoran, A, Thistlethwaite, FC, Evans, MJ, Colledge, WH,
Friedman, LS, Ponder, BA, Venkitaraman, AR., 1998. Involvement of Brca2 in DNA
repair. Mol. Cell 1 (3), 347–357.
Paterson, M.C., Anderson, AK, Smith, BP, Smith, PJ., 1979. Enhanced radiosensitivity of
cultured fibroblasts from ataxia telangiectasia heterozygotes manifested by defective
colony-forming ability and reduced DNA repair replication after hypoxic gamma-
irradiation. Cancer Res. 39 (9), 3725–3734.
Rivera-Rivera, Y., Saavedra, H.I., 2016. Centrosome - a promising anti-cancer target.
Biologics 10, 167–176.
Sato, C., Kuriyama, R., Nishizawa, K., 1983. Microtubule-organizing centers abnormal in
number, structure, and nucleating activity in x-irradiated mammalian cells. J. Cell
Biol. 96 (3), 776–782.
Shafman, T., Khanna, KK, Kedar, P, Spring, K, Kozlov, S, Yen, T, Hobson, K, Gatei, M,
Zhang, N, Watters, D, Egerton, M, Shiloh, Y, Kharbanda, S, Kufe, D, Lavin, MF., 1997.
Interaction between ATM protein and c-Abl in response to DNA damage. Nature 387
(6632), 520–523.
Shen, K., Wang, Y, Brooks, SC, Raz, A, Wang, YA., 2006. ATM is activated by mitotic
stress and suppresses centrosome amplification in primary but not in tumor cells. J.
Cell. Biochem. 99 (5), 1267–1274.
Somasundaram, K., Zhang, H, Zeng, YX, Houvras, Y, Peng, Y, Zhang, H, Wu, GS, Licht, JD,
Weber, BL, El-Deiry, WS., 1997. Arrest of the cell cycle by the tumour-suppressor
BRCA1 requires the CDK-inhibitor p21WAF1/CiP1. Nature 389 (6647), 187–190.
Sridharan, D.M., Chappell, LJ, Whalen, MK, Cucinotta, FA, Pluth, JM., 2015. Defining the
biological effectiveness of components of high-LET track structure. Radiat. Res. 184
(1), 105–119.
Sridharan, D.M., Enerio, S, LaBarge, MA, Stampfer, MM, Pluth, JM., 2017. Lesion com-
plexity drives age related cancer susceptibility in human mammary epithelial cells.
Aging 9 (3), 665–686.
Sudo, H., Garbe, J, Stampfer, MR, Barcellos-Hoff, MH, Kronenberg, A., 2008. Karyotypic
instability and centrosome aberrations in the progeny of finite life-span human
mammary epithelial cells exposed to sparsely or densely ionizing radiation. Radiat.
Res. 170 (1), 23–32.
Swift, M., Morrell, D, Cromartie, E, Chamberlin, AR, Skolnick, MH, Bishop, DT., 1986.
The incidence and gene frequency of ataxia-telangiectasia in the United States. Am. J.
Hum. Genet. 39 (5), 573–583.
Tutt, A., Gabriel, A, Bertwistle, D, Connor, F, Paterson, H, Peacock, J, Ross, G, Ashworth,
A., 1999. Absence of Brca2 causes genome instability by chromosome breakage and
D.M. Sridharan et al. Life Sciences in Space Research 20 (2019) 101–112
111
loss associated with centrosome amplification. Curr. Biol. 9 (19), 1107–1110.
Walsh, M.F., Nathanson, KL, Couch, FJ, Offit, K., 2016. Genomic biomarkers for breast
cancer risk. Adv. Exp. Med. Biol. 882, 1–32.
Wang, R.H., Yu, H., Deng, C.X., 2004. A requirement for breast-cancer-associated gene 1
(BRCA1) in the spindle checkpoint. Proc. Natl. Acad. Sci. USA 101 (49),
17108–17113.
Weeks, D.E., Paterson, MC, Lange, K, Andrais, B, Davis, RC, Yoder, F, Gatti, RA., 1991.
Assessment of chronic gamma radiosensitivity as an in vitro assay for heterozygote
identification of ataxia-telangiectasia. Radiat. Res. 128 (1), 90–99.
Weissberg, J.B., Huang, D.D., Swift, M., 1998. Radiosensitivity of normal tissues in ataxia-
telangiectasia heterozygotes. Int. J. Radiat. Oncol. Biol. Phys. 42 (5), 1133–1136.
Xu, X., Weaver, Z, Linke, SP, Li, C, Gotay, J, Wang, XW, Harris, CC, Ried, T, Deng, CX.,
1999. Centrosome amplification and a defective G2-M cell cycle checkpoint induce
genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol. Cell 3 (3), 389–395.
Zhou, B.B., Elledge, S.J., 2000. The DNA damage response: Putting checkpoints in per-
spective. Nature 408 (6811), 433–439.
D.M. Sridharan et al. Life Sciences in Space Research 20 (2019) 101–112
112
